Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of the ANR Lamorsim project (https://anr.fr/Project-ANR-23-CE08-0029 ). The main objective of this project is to develop methodologies for achieving controlled laser-induced amorphization of silicon. In this
-
characterization of novel ultra-stable laser sources based on rare-earth ion-doped optical fibers (erbium, neodymium, or thulium) using fiber components functionalized by femtosecond photoinscription. The project
-
cutting-edge optical setups, femtosecond laser systems, analysis tools and modeling. Requirements: Completed university studies with a Master degree preferentially in physics. Desirable: • Experience in
-
Experience with femtosecond lasers Experience at large scale facility (e.g. SR, FEL) would be an asset Knowledge in UHV and X-ray spectroscopy would be advantageous Strong motivation to participate in SCS user
-
in photonics that includes a clear femtosecond fibre laser expertise (master project) A strong expertise in femtosecond pulse measurements An expertise in technical drawing of system. An expertise in
-
and X-ray techniques with temporal resolution from femtoseconds to picoseconds. Further information is available on the website: https://ipr.univ-rennes.fr/en/materials-and-light-departement Where
-
this role, we are looking for candidates to have the following skills and experience: Essential criteria A master in photonics that includes a clear femtosecond fibre laser expertise (master project) A strong
-
and optoelectronics, with particular emphasis on techniques used for optical imaging of the human retina. It centers on two-photon fluorescence ophthalmoscopy employing femtosecond laser sources
-
ophthalmoscopy employing femtosecond laser sources. This technique offers new opportunities for early diagnosis of retinal diseases and for testing innovative gene therapies. Within the project, we will develop
-
ophthalmoscopy employing femtosecond laser sources. This technique offers new opportunities for early diagnosis of retinal diseases and for testing innovative gene therapies. Within the project, we will develop